Soleno Therapeutics (SLNO) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.90% |
| Dec 31, 2025 | -6.01% |
| Sep 30, 2025 | 80.52% |
| Jun 30, 2025 | 4.47% |
| Mar 31, 2025 | -3.89% |
| Dec 31, 2024 | 11.55% |
| Sep 30, 2024 | -2.44% |
| Jun 30, 2024 | 80.13% |
| Mar 31, 2024 | -6.56% |
| Dec 31, 2023 | 184.34% |
| Sep 30, 2023 | 105.36% |
| Jun 30, 2023 | 58.40% |
| Mar 31, 2023 | -26.27% |
| Dec 31, 2022 | -17.14% |
| Sep 30, 2022 | -13.24% |
| Jun 30, 2022 | -13.36% |
| Mar 31, 2022 | 19.67% |
| Dec 31, 2021 | -16.47% |
| Sep 30, 2021 | -12.74% |
| Jun 30, 2021 | -13.98% |
| Mar 31, 2021 | -12.74% |
| Dec 31, 2020 | -9.48% |
| Sep 30, 2020 | -8.97% |
| Jun 30, 2020 | 145.57% |
| Mar 31, 2020 | -15.87% |
| Dec 31, 2019 | 32.89% |
| Sep 30, 2019 | -15.85% |
| Jun 30, 2019 | -12.18% |
| Mar 31, 2019 | -9.93% |
| Dec 31, 2018 | 39.94% |
| Sep 30, 2018 | -7.52% |
| Jun 30, 2018 | -8.22% |
| Mar 31, 2018 | -6.90% |
| Dec 31, 2017 | 47.91% |
| Sep 30, 2017 | -13.16% |
| Jun 30, 2017 | -10.29% |
| Mar 31, 2017 | 508.55% |
| Dec 31, 2016 | -33.03% |
| Sep 30, 2016 | 50.12% |
| Jun 30, 2016 | -41.05% |
| Mar 31, 2016 | 14.50% |
| Dec 31, 2015 | 12.53% |
| Sep 30, 2015 | -16.90% |
| Jun 30, 2015 | -12.88% |
| Mar 31, 2015 | 19.90% |
| Dec 31, 2014 | 395.04% |